Adma Biologics reported $398.32M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Adma Biologics USD 398.32M 49.3M Jun/2025
Alnylam Pharmaceuticals USD 250.59M 135.16M Jun/2025
Dynavax Technologies USD 494.16M 36.78M Jun/2025
Takeda JPY 6.87T 69.82B Jun/2025